Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-04-000004

President and CEO sold 32,450 shares at $6.87 ($222,932)

  • President and CEO acquired 32,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HARRIS ROBERT B President and CEO 2004-03-12 Option exercise +25,381 76,502 D
HARRIS ROBERT B President and CEO 2004-03-12 Option exercise +7,069 83,571 D
HARRIS ROBERT B President and CEO 2004-03-12 Sale −25,381 $6.87 $174,367 58,190 D
HARRIS ROBERT B President and CEO 2004-03-12 Sale −7,069 $6.87 $48,564 51,121 D
Derivatives
HARRIS ROBERT B President and CEO 2004-03-12 Option exercise · Stock Options −25,381 126,529 D
HARRIS ROBERT B President and CEO 2004-03-12 Option exercise · Stock Options −7,069 119,460 D
Open-market sales · 32,450 sh · avg $6.87 · $222,932
Loading xslF345X02/primary_doc.xml…